Abstract
In many types of malignancy, ascites is a prognostic sign of advanced stage, with a survival rate of 11% for patients with ascites more than 6 months. Currently, combination therapy has become the ...
Cite
CITATION STYLE
APA
Elkhawaga, O.-A., Gebril, S., & Salah, N. (2019). Evaluation of anti-tumor activity of metformin against Ehrlich ascites carcinoma in Swiss albino mice. Egyptian Journal of Basic and Applied Sciences, 6(1), 116–123. https://doi.org/10.1080/2314808x.2019.1676003
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free